Dose requirements for UVC disinfection of catheter biofilms

Bacterial biofilms on permanent catheters are the major sources of infection. Exposure to ultraviolet-C (UVC) light has been proposed as a method for disinfecting the inner surface of catheters. Specification of a UVC-based device for in vivo disinfection is based on the knowledge of the required doses to kill catheter biofilm. Given these doses and the power of available UVC light sources, calculation of the necessary treatment times is then possible. To determine the required doses, contaminated urinary catheters were used as test samples and UVC treated in vitro. Patient catheters (n = 67) were collected and cut into segments of equal size and treated with various UVC doses. After treatment, the biofilm was removed by scraping and quantified by counting colony forming units. Percentage killing rates were determined by calculating ratios between UVC-treated samples and controls (no UVC treatment). Mean killing rates were 89.6% (0.5 min), 98% (2 min), and 99% (60 min). Approximately 99% killing was obtained with a UVC dose of 15 kJ m−2. This dose, which is about 100 to 1000 times greater than the lethal dose for planktonic cells, is expected to be the maximum dose required to maintain newly inserted catheters free of contamination. The combination of high doses required to kill mature biofilm and the limited effect of current UVC light sources result in a relative long treatment time (∼60 min). If a UVC-based method is to be of practical use for disinfection of catheters in the clinic, repeated preventive treatments should be carried out on newly inserted catheters.

[1]  R. Darouiche,et al.  Treatment of infections associated with surgical implants. , 2004, The New England journal of medicine.

[2]  B. Farr,et al.  Diagnosis and management of long-term central venous catheter infections. , 2004, Journal of vascular and interventional radiology : JVIR.

[3]  BAS Dale,et al.  Intravascular-catheter-related infections , 1998, The Lancet.

[4]  Deborah Braccia,et al.  Systematic review of economic analyses of health care-associated infections. , 2005, American journal of infection control.

[5]  I. Raad,et al.  In Vitro and Ex Vivo Activities of Minocycline and EDTA against Microorganisms Embedded in Biofilm on Catheter Surfaces , 2003, Antimicrobial Agents and Chemotherapy.

[6]  E. Anaissie,et al.  Ultrastructural analysis of indwelling vascular catheters: a quantitative relationship between luminal colonization and duration of placement. , 1993, The Journal of infectious diseases.

[7]  M. Parsek,et al.  A Sticky Business: the Extracellular Polymeric Substance Matrix of Bacterial Biofilms , 2004 .

[8]  S. Wuertz,et al.  UV disinfection in a model distribution system:; biofilm growth and microbial community. , 2004, Water research.

[9]  J. Costerton,et al.  Antibiotic resistance of bacteria in biofilms , 2001, The Lancet.

[10]  Benli Chai,et al.  Survival of Shewanella oneidensis MR-1 after UV Radiation Exposure , 2004, Applied and Environmental Microbiology.

[11]  S. Percival,et al.  Use of In Vivo-Generated Biofilms from Hemodialysis Catheters To Test the Efficacy of a Novel Antimicrobial Catheter Lock for Biofilm Eradication In Vitro , 2004, Journal of Clinical Microbiology.

[12]  M. Morgan,et al.  Effect of vancomycin and rifampicin on meticillin-resistant Staphylococcus aureus biofilms , 2001, The Lancet.

[13]  M. G. Woodbury,et al.  Ultraviolet light C in the treatment of chronic wounds with MRSA: a case study. , 2002, Ostomy/wound management.

[14]  Leonard Mermel,et al.  Prevention of Intravascular CatheterRelated Infections , 1994, Annals of Internal Medicine.

[15]  I. Raad,et al.  Intravascular catheter-related infections: new horizons and recent advances. , 2002, Archives of internal medicine.

[16]  D. Mara,et al.  The resurgence of tuberculosis in the tropics. An engineering approach to the control of Mycobacterium tuberculosis and other airborne pathogens: a UK hospital based pilot study. , 2000, Transactions of the Royal Society of Tropical Medicine and Hygiene.

[17]  K. Jeejeebhoy,et al.  Taurolidine lock: the key to prevention of recurrent catheter-related bloodstream infections. , 2005, Clinical nutrition.

[18]  R. Haley,et al.  The nationwide nosocomial infection rate. A new need for vital statistics. , 1985, American journal of epidemiology.